News Brief
Uttarakhand Government Suspends Manufacturing Licences Of 14 Patanjali Products: Here's The Full List
Kuldeep Negi
Apr 30, 2024, 08:24 AM | Updated 08:24 AM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
The Uttarakhand government has informed the Supreme Court that it has suspended the manufacturing licences for 14 Patanjali products.
In an affidavit, the state government told the apex court that it has also granted permission to file a complaint against Baba Ramdev's Divya Pharmacy and Patanjali Ayurved Ltd for repeated violations of the drug advertisements law.
The State Licensing Authority, Ayurvedic and Unani Services, had issued a public notice intimating that publication of advertisements contrary to the law would entail strict disciplinary and legal action, including fine, imprisonment, or both.
Following this, permission was granted on 12 April to the Drug Inspector, Haridwar for filing a complaint against Divya Pharmacy and Patanjali Ayurved Ltd. for repeated violations of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
The suspended manufacturing licenses affect products such as 'Swasari Gold', 'MuktaVati Extra Power', and 'Livamrit Advance,' among others, under Rule 159(1) of The Drugs and Cosmetics Rules, 1945.
The other products whose manufacturing licences have been suspended are 'Swasari Vati', 'Bronchom', 'Swasari Pravahi', 'Swasari Avaleh', 'Lipidom', 'Bp Grit', 'Madhugrit', 'MadhunashiniVati Extra Power', 'Livogrit', 'Eyegrit Gold' and 'Patanjali Drishti Eye Drop', NDTV reported.
The affidavit also mentions a criminal complaint filed against key figures associated with Divya Pharmacy and Patanjali Ayurved Ltd., including Swami Ramdev and Acharya Balkrishna, under relevant sections of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
It asserts that the State Licensing Authority will continue taking necessary legal steps against the companies as prescribed by law and directed by the Supreme Court.
This action comes after the Indian Medical Association raised concerns about violations of the Drugs and Magic Remedies (Objectionable Advertisements) Act, particularly regarding the advertisement of products for specified diseases and disorders like diabetes, heart diseases, high or low blood pressure, and obesity.
Patanjali Ayurved Ltd. had previously committed to the Supreme Court that it would refrain from making any casual statements claiming the medicinal efficacy of its products or advertise or brand them in violation of law and would not release any statement against any system of medicine to the media in any form.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Kuldeep is Senior Editor (Newsroom) at Swarajya. He tweets at @kaydnegi.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
